Birmingham, West Midlands -- (SBWIRE) -- 12/18/2013 -- Value Penny Stocks issues special report on People's United Financial, Inc (NASDAQ:PBCT), CombiMatrix Corporation (NASDAQ:CBMX), Rentech, Inc. (NASDAQ:RTK), Orexigen Therapeutics, Inc. (NASDAQ:OREX).
People's United Financial, Inc. (NASDAQ:PBCT) opened its last trade at the price of $14.67. Its closing price was $14.63 after losing -0.27% for the day. The company traded with the total volume of 2,751,417 shares, while its average trading volume remained 2.57 million shares. The beta of this stock stands at 00.4. People’s United Financial, Inc. operates as the bank holding company for People’s United Bank that provides commercial banking, retail and business banking, and wealth management services to individual, corporate, and municipal customers.
Has PBCT Found The Bottom and Ready To Move Up? Find Out Here
CombiMatrix Corporation (NASDAQ:CBMX) percentage change plunged -19.30% to close at $2.30 with the total traded volume of 2,723,974 shares, along with average volume of 1.17 million shares. The 52 week range of the stock remained $2.14 - $7.64, while its day lowest price was $2.14. The share price hit the day highest price of $2.50. CombiMatrix Corporation, a molecular diagnostics company, operates primarily in the field of genetic analysis and molecular diagnostics. The company, through its subsidiary, CombiMatrix Molecular Diagnostics, Inc., operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, clinics, and other laboratories in the areas of prenatal and postnatal development disorders, and hematology/oncology genomics.
Has CBMX Found The Bottom And Ready To Gain Momentum? Find Out Here
Rentech, Inc. (NASDAQ:RTK) traded on volume of 2,705,335 shares in the last session against average volume of 2.11 million shares. The company started its trading session with the price of $1.68 and closed at $1.65 by scoring -2.94%. Rentech, Inc., through its subsidiaries, engages in the manufacture and sale of natural-gas based nitrogen fertilizer products in the United States and Brazil. Its products include ammonium sulfate, sulfuric acid, and ammonium thiosulfate used in the production of corn, soybeans, potatoes, cotton, canola, alfalfa, and wheat.
Why Should Investors Buy RTK After the Recent Fall? Just Go Here and Find Out
Orexigen Therapeutics, Inc. (NASDAQ:OREX) started its last trading session with the price of $5.48 and closed at $5.38 by scoring -2.36%. The stock traded with total volume of 2,668,902 shares, while the average trading volume remained 2.75 million shares. The beta value of this stock stands at 2.14. Day range for the stock was $5.32 - $5.51. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic, which has completed Phase II clinical trials.
Will OREX Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)